Biohaven Ltd (BHVN)

Feb 15, 2025

(BHVN) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 15, 2025

Feb 14, 2025

Biohaven's troriluzole gains FDA priority review for SCA - MSN

Feb 14, 2025

Feb 14, 2025

Biohaven (NYSE:BHVN) Now Covered by Deutsche Bank Aktiengesellschaft - MarketBeat

Feb 14, 2025

Feb 14, 2025

Biohaven stock rises following FDA review and Deutsche Bank's buy rating - MSN

Feb 14, 2025

Feb 14, 2025

Biohaven (NYSE:BHVN) Shares Gap UpWhat's Next? - MarketBeat

Feb 14, 2025

Feb 13, 2025

WCM Investment Management LLC Takes Position in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Feb 13, 2025

Feb 13, 2025

Mississippi to receive$162.2K of $59.7M Settlement Over Alleged Biohaven Kickbacks - Vicksburg Daily News

Feb 13, 2025

Feb 13, 2025

Biohaven Ltd. Receives FDA Priority Review for Troriluzole, Boosting Investor Confidence - TipRanks

Feb 13, 2025

Feb 11, 2025

Why Biohaven Stock Triumphed on Tuesday - The Motley Fool

Feb 11, 2025

Feb 11, 2025

Biohaven: NDA Review Of Troriluzole Isn't Only 2025 Catalyst On Deck - Seeking Alpha

Feb 11, 2025

Feb 11, 2025

Biohaven, Ecolab, Firefly - TradingView

Feb 11, 2025

Feb 11, 2025

Biohaven: Highly Priced Biotech With Broad Pipeline But No Revenues (NYSE:BHVN) - Seeking Alpha

Feb 11, 2025

Feb 11, 2025

Biohaven stock rises following FDA review and Deutsche Bank’s buy rating - Investing.com Nigeria

Feb 11, 2025

Feb 11, 2025

Biohaven stock rises following FDA review and Deutsche Bank's buy rating By Investing.com - Investing.com South Africa

Feb 11, 2025

Feb 11, 2025

Biohaven Says FDA Grants Priority Review to Neurodegenerative Disorder Drug; Shares Rise - Marketscreener.com

Feb 11, 2025

Feb 11, 2025

Biohaven’s troriluzole NDA in spinocerebellar ataxia accepted by the FDA - TipRanks

Feb 11, 2025

Feb 11, 2025

Why Biohaven Ltd. Shares Are Tumbling? - TipRanks

Feb 11, 2025

Feb 11, 2025

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia - PR Newswire

Feb 11, 2025

Feb 10, 2025

Jennison Associates LLC Makes New $3.64 Million Investment in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Feb 10, 2025

Feb 06, 2025

China Universal Asset Management Co. Ltd. Makes New $575,000 Investment in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Feb 06, 2025

Feb 05, 2025

Biohaven Kickback Case Settled For $59M - NewsBreak

Feb 05, 2025

Feb 05, 2025

SG Americas Securities LLC Has $336,000 Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World

Feb 05, 2025

Feb 05, 2025

Biohaven Ltd.’s Promising Outlook for Troriluzole in Spinocerebellar Ataxia Amidst FDA Decision - TipRanks

Feb 05, 2025

Feb 04, 2025

Biohaven FY2025 EPS Forecast Decreased by Leerink Partnrs - MarketBeat

Feb 04, 2025

Feb 04, 2025

(BHVN) Technical Data - Stock Traders Daily

Feb 04, 2025

Feb 01, 2025

Leerink Partnrs Decreases Earnings Estimates for Biohaven - Defense World

Feb 01, 2025

Jan 29, 2025

Nebraska Joins in Settling Kickback Allegations against Biohaven Pharmaceutical Holding Company Ltd. - Rural Radio Network

Jan 29, 2025

Jan 29, 2025

Nebraska joins in settling kickback allegations against Biohaven - norfolkneradio.com

Jan 29, 2025

Jan 29, 2025

Pfizer to pay nearly $60M over kickbacks for migraine drug developed by New Haven-based Biohaven - Hartford Business Journal

Jan 29, 2025

Jan 29, 2025

Multiple System Atrophy (MSA) Market 2025-2032 Business - openPR

Jan 29, 2025

Jan 28, 2025

Nebraska joins multi-state settlement against Biohaven Pharmaceutical for kickback allegations - NEWS CHANNEL NEBRASKA

Jan 28, 2025

Jan 28, 2025

Nebraska joins in settling kickback allegations against Biohaven Pharmaceutical Holding Company Ltd. - News Channel Nebraska

Jan 28, 2025